| Summary: | Some three decades after bone marrow transplantation was introduced in the field of hematology and oncology, transplantation today continues to rapidly grow and expand into a variety of new modalities. Peripheral blood has been established as an effective source of autologous progenitor cells. Furthermore, the graft-versus-leukemia effect has resulted in novel strategies of adoptive immunotherapy for cancer. Finally, approaches to gene transfer and therapy can utilize transplantation methodologies and augment their effects. The present volume provides first-hand reports from leading groups covering approaches to stem cells, normal and leukemic; stem cell sources and donors; cellular immune therapy; minimal residual disease, monitoring and treatment; clinical autologous transplantation; and gene therapy, as well as the history and the state of the art of transplantation in hematology and oncology
|
|---|